• Science News
    For the Alzheimer’s community, new drugs cannot come fast enough. In recent years, trials of disease-modifying drugs have been disappointing, yet they’ve brought valuable knowledge about the optimal timing for when Alzheimer’s can be stopped. Today, there’s a sense that a breakthrough is near. There’s a quantum leap of activity aimed at slowing down Alzheimer’s decades before symptoms appear.
    November 12, 2014
  • Science News
    Optical coherence tomography (OCT), magnetic resonance imaging (MRI), and other techniques are improving our ability to look deep inside the eye. Thanks to National Glaucoma Research funding, BrightFocus researchers are among those who have advanced new imaging methods, taking them from experimental stages to their new threshold, where they wait to become standard as clinical tools.
    October 29, 2014
  • Science News
    It may seem too good to be true, but your brain works better on chocolate, according to a small study just published online in the journal, Nature Neuroscience. Dark chocolate, that is. Processing for milk chocolate gets rid of the helpful compounds.
    October 27, 2014
  • Science News
    BrightFocus grantee Huaxi Xu, PhD and colleagues at the Sanford-Burnham Medical Research Institute in La Jolla, CA, have published a paper that sheds light on the origins and connections between the characteristic amyloid plaques found in the brains of individuals with Alzheimer’s disease and the predisposition of individuals with Down syndrome to develop the same plaques, and exhibit Alzheimer’s-type dementia, as they age.
    October 24, 2014
  • Science News
    Rudolph E. Tanzi, PhD and Se Hoon Choi, PhD have managed to accomplish what no one has done before. They grew human brain cells in a petri dish using a gel culture, and then infiltrated them with genes that encode for amyloid precursor protein and presenilin1, both of which were earlier discoveries in Tanzi’s lab and are associated with the most robustly inheritable, early-onset familial forms of Alzheimer’s disease.
    October 16, 2014
  • Science News
    It’s just been announced that Jeffrey Goldberg, MD, PhD, of the University of California, San Diego (UCSD) will share a $1 million grant from the U.S. Department of Defense (DoD) for a two-year project to develop whole-eye transplantation techniques in an animal model.
    September 25, 2014
  • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Keep me informed about: *
    Please select at least one.
    You must select at least one disease category.
    Please enter your first name.
    Please enter your last name.